Pulmonary Artery Banding for Children With Dilated Cardiomyopathy: US Experience

Zachary A Spigel1, Anees Razzouk2, John J Nigro3

  • 1Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.

Insights

Pulmonary artery banding shows promise for dilated cardiomyopathy. Outcomes varied between US and German centers, possibly due to patient preoperative status, highlighting the need for further research in patient selection.

Area of Science:

  • Cardiology
  • Pediatric Cardiac Surgery
  • Heart Failure Management

Background:

  • Pulmonary artery banding is an emerging therapy for dilated cardiomyopathy with preserved right ventricular function.
  • Initial reports originated from Germany, prompting a need to evaluate its efficacy in other regions.

Purpose of the Study:

  • To present the multicenter retrospective experience with pulmonary artery banding in the United States.
  • To compare US outcomes with previously reported German data.

Main Methods:

  • A retrospective review of 14 patients who underwent pulmonary artery banding across five US centers.
  • Comparison of preoperative characteristics and outcomes between US and German cohorts.

Main Results:

  • The US cohort (n=14) had a median age of 5 months; 75% required mechanical ventilation and 93% used inotropes preoperatively.
  • Outcomes included 29% cardiac recovery, 57% bridged to transplant (6 with VAD), and 14% mortality.
  • The US cohort had a lower recovery rate (<1/3) compared to Germany (>2/3), potentially linked to sicker preoperative status (75% intubated vs <33%).

Conclusions:

  • Pulmonary artery banding can serve as a bridge to transplant or facilitate recovery in pediatric dilated cardiomyopathy.
  • Differences in outcomes between US and German centers may reflect variations in patient selection and preoperative disease severity.
  • Further investigation is needed to optimize patient selection and timing for pulmonary artery banding.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
335
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
219
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
278